Does a Biopsy Spread Cancer? Staging and Surgery Myths

A biopsy does not spread cancer. Numerous studies have shown that taking tissue from a tumour does not cause the disease to spread, and a firm diagnosis of cancer requires that tissue. Dr. Mohit Agarwal, Principal Director & Head Medical Oncology, Fortis Hospital, Shalimar Bagh, New Delhi, India, regards modern CT-guided biopsy as so safe that there is no reason not to perform it.

The decisions that most often go wrong in cancer care are made in the first few weeks: whether to biopsy, how far to investigate, and whether to operate. Dr. Agarwal sees the consequences regularly. Patients fear that a biopsy will spread the disease. Others are reassured by normal blood tests and ignore a lump. Still others undergo surgery on a primary tumour when the disease has already spread, gaining nothing and losing time and money. His teaching on diagnosis and local treatment is, in effect, a guide to avoiding those errors.

This article covers biopsy, investigation, staging, surgery and radiotherapy. The broader picture of risk, warning signs and screening is in the complete guide to cancer myths, facts and advances.

Does a biopsy spread cancer?

No. A firm diagnosis of cancer requires tissue, which means a biopsy: the removal of a small sample of tissue for examination. Many patients believe that once a needle enters a tumour, the cancer will spread. Dr. Agarwal is unequivocal that it does not: numerous studies have shown that cancer does not spread as a result of a biopsy. His message to patients is that cutting into a cancer to diagnose it does not cause it to spread. Seeding of tumour cells along the needle track is rare, and for a few tumours, such as sarcoma or suspected testicular cancer, the specialist team plans the biopsy route so that it does not compromise later surgery.

Why a biopsy is needed before treatment

A biopsy is needed because a mass that looks like cancer is not always cancer. Across Africa and India, Dr. Agarwal notes, tuberculosis and other infections regularly mimic malignancy. A patient thought to have cancer turns out to have tuberculosis, a treatable infection that would have been mismanaged entirely without tissue. Treating on clinical suspicion alone risks both errors: giving chemotherapy to a patient with an infection, and missing the cancer in a patient who has one.

Is a CT-guided biopsy safe?

Modern technique makes the procedure both precise and safe. Dr. Agarwal illustrates this with a lung cancer case: a CT cross-section shows the mass, and the biopsy needle, guided by CT, passes directly into it to retrieve a core of tissue. In his view, the procedure is now so safe that there is no reason not to perform it.

Know the enemy

Dr. Agarwal frames diagnosis as knowing the enemy. A biopsy does more than confirm cancer. It identifies the type of cancer and, increasingly, the molecular features that decide treatment. The same specimen is sectioned, stained and tested for the targets that guide modern drug therapy, as described in the article on personalised cancer treatment and NGS. Without tissue, none of that is possible.

Can normal blood tests rule out cancer?

Normal routine blood tests do not rule out cancer, because the blood is usually not affected in the early stages of the disease. A common pattern, at least among patients in India, is to respond to a worrying symptom with a routine blood panel: a haemogram (complete blood count), kidney function tests and liver function tests. When the results come back normal, patients set aside the lump or the other warning signs. Dr. Agarwal is clear that this is a mistake. A normal haemogram, kidney function or liver function test does not exclude cancer, and it is never a reason to ignore a symptom that warrants investigation.

The underlying logic is worth spelling out for patients. Routine blood tests measure the function of the bone marrow, kidneys and liver. An early tumour in the breast or the lung generally leaves all three untouched. By the time those tests become abnormal, the disease is often advanced. Relying on them as a screen for cancer therefore selects for late diagnosis.

Why cancer staging matters before treatment

Cancer must be staged before treatment begins, because the right treatment depends on the type of cancer, its site and its stage. Many patients assume that treatment must begin the moment cancer is diagnosed; Dr. Agarwal's answer is that the disease must first be staged.

Cancer is conventionally described in four stages:

• Stage I: an early cancer, confined to the organ where it began.
• Stage II: a larger tumour or one with limited local spread.
• Stage III: locally advanced disease, typically involving nearby lymph nodes or structures.
• Stage IV: cancer that has gone beyond its own premises and spread to distant organs.

Because stage is one of the three inputs, treatment cannot be planned until it is known. Dr. Agarwal regularly sees patients with stage four disease who have undergone surgery on the primary site. In those cases, he says, the operation was not indicated and did not help. It wasted the patient's time and money. Proper staging, in his view, is a must before any cancer treatment.

How to stage cancer without PET-CT

Where PET-CT is unavailable, the second-best way to stage cancer is CT scanning of every probable area of spread. PET-CT is a whole-body scan that combines positron emission tomography with CT. Many of the doctors in Dr. Agarwal's audience work in countries where it is not available, a constraint raised in the masterclass Live Discussion, and are forced into guesswork about the extent of disease. Dr. Agarwal's advice is pragmatic: scan the chest, abdomen and, depending on the cancer, the head and neck. These scans will give useful answers about the stage of the disease.

Is surgery always necessary for cancer?

Surgery is not always the right treatment for cancer; which modality is right depends entirely on which disease is being treated. Patients often equate cancer treatment with removing the tumour. Dr. Agarwal's first counter-example is lymphoma. A lymphoma can present as a simple lump in the neck, and the instinct is to remove the lump and declare the patient cured. That does not work. Lymphoma is a disease of the blood and lymphatic system, so it is already present beyond the visible lump. The correct treatment is medical: systemic therapy, with no surgery required, and with it the patient can be cured.

Why treatment before surgery is now common

Two decades ago, surgery was usually the first step. Today, in many cancers, the sequence has changed. Patients are often given drug treatment first, known as neoadjuvant therapy, to shrink the tumour, so that the subsequent operation achieves a better result.

The reasoning turns on completeness. If a surgeon removes a tumour but leaves any portion of it behind, the operation has largely been wasted. Shrinking the tumour first makes complete removal more achievable. It follows that every test needed to establish the exact disease and its extent should be complete before a patient goes to theatre. Surgery is a single opportunity, and it should be taken with full information.

Why does cancer come back after surgery?

Cancer can come back after surgery because some cells may survive in the body, beyond the reach of the surgeon and below the threshold of any scan. Even a technically complete operation does not guarantee cure. Dr. Agarwal describes treating those residual cells as a central aim of care after surgery. This is the rationale for treatment given after an operation, known as adjuvant therapy, even when the visible tumour has been fully removed.

Lumpectomy vs mastectomy: is removing the whole breast safer?

Removing the whole breast is not, in itself, safer than removing only the lump: Dr. Agarwal points out that trials have shown breast-conserving surgery and mastectomy deliver equal outcomes. Breast cancer is one of the most common cancers, and this is one of the most persistent myths surrounding its surgery. Many patients assume that removing the entire breast is safer, on the principle of "the more the merrier". It is not.

That evidence comes from long-term randomised trials comparing lumpectomy plus radiotherapy with mastectomy, which found no difference in overall survival over decades of follow-up. Breast-conserving surgery (lumpectomy) followed by radiotherapy has since become the standard for suitable patients, in whom only the tumour and a margin of healthy tissue are removed. Mastectomy remains the right choice for some women, for example when the tumour is large relative to the breast, when disease is present in several parts of the breast, or when radiotherapy is not possible. The point Dr. Agarwal makes stands: removing more tissue does not, in itself, improve the chance of cure. Indicative prices for both operations are on the breast cancer surgery cost page.

Does radiotherapy burn? How modern radiotherapy works

Modern radiotherapy does not burn indiscriminately: computerised planning delivers the dose to the specific site of the tumour while sparing the adjoining tissue. Patients often fear that radiotherapy will burn them. Dr. Agarwal explains that radiotherapy uses ionising radiation, the same kind of energy used in an X-ray, and that modern radiotherapy is highly precise. The image of radiation as an indiscriminate burn belongs to an earlier era of treatment. Indicative prices are on the radiotherapy cost page.

What a comprehensive cancer centre adds

A comprehensive centre shortens the time from biopsy to treatment, because every step happens in one place. Dr. Agarwal describes Fortis Hospital, Shalimar Bagh, as a quaternary care centre with about 400 beds in which everything is done in-house. The practical benefit is speed: when imaging, pathology, genomic testing and treatment sit under one roof, turnaround times are short. The centre offers PET scanning, advanced radiotherapy platforms, targeted therapy and immunotherapy, a large day-care unit for outpatient treatment, interventional radiology and lutetium-based radionuclide therapy. In his words, any treatment that is the standard of care worldwide is available there.

For a referring doctor, the significance is less the equipment list than the sequence it enables. A patient can be biopsied, staged by PET-CT, tested for molecular targets and started on the appropriate treatment without the delays that accumulate when each step happens in a different place.